Kathryn E. Oliver

404 total citations
15 papers, 233 citations indexed

About

Kathryn E. Oliver is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Kathryn E. Oliver has authored 15 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Kathryn E. Oliver's work include Cystic Fibrosis Research Advances (12 papers), Legume Nitrogen Fixing Symbiosis (3 papers) and Bacterial Genetics and Biotechnology (3 papers). Kathryn E. Oliver is often cited by papers focused on Cystic Fibrosis Research Advances (12 papers), Legume Nitrogen Fixing Symbiosis (3 papers) and Bacterial Genetics and Biotechnology (3 papers). Kathryn E. Oliver collaborates with scholars based in United States, Germany and Netherlands. Kathryn E. Oliver's co-authors include Eric J. Sorscher, Zoya Ignatova, John L. Hartman, Jens Meiler, Jonathan P. Schlebach, Robert Rauscher, Eli Fritz McDonald, Garry R. Cutting, Sangwoo T. Han and Lars Plate and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Kathryn E. Oliver

14 papers receiving 232 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathryn E. Oliver United States	9	136	111	42	27	15	15	233
Carleen Mae P. Sabusap United States	6	125 0.9×	62 0.6×	24 0.6×	21 0.8×	10 0.7×	6	164
Mallory R. Stroik United States	6	120 0.9×	152 1.4×	41 1.0×	41 1.5×	15 1.0×	10	269
Heather Davidson United Kingdom	8	142 1.0×	112 1.0×	49 1.2×	7 0.3×	15 1.0×	9	238
Damien Paulet France	6	26 0.2×	94 0.8×	13 0.3×	24 0.9×	21 1.4×	9	152
Thanh Tung Truong United States	5	72 0.5×	385 3.5×	83 2.0×	27 1.0×	12 0.8×	8	467
Kamila M Pytel United Kingdom	4	98 0.7×	38 0.3×	38 0.9×	6 0.2×	14 0.9×	6	161
Lauren S. Mogil United States	7	32 0.2×	131 1.2×	81 1.9×	13 0.5×	5 0.3×	9	228
David Cano-Rodríguez Netherlands	6	23 0.2×	287 2.6×	62 1.5×	20 0.7×	11 0.7×	8	321
Damien Ulveling France	9	20 0.1×	176 1.6×	40 1.0×	12 0.4×	14 0.9×	13	261
Fredrik Fagerström‐Billai Sweden	7	30 0.2×	269 2.4×	67 1.6×	43 1.6×	13 0.9×	8	315

Countries citing papers authored by Kathryn E. Oliver

Since Specialization

Citations

This map shows the geographic impact of Kathryn E. Oliver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn E. Oliver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn E. Oliver more than expected).

Fields of papers citing papers by Kathryn E. Oliver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn E. Oliver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn E. Oliver. The network helps show where Kathryn E. Oliver may publish in the future.

Co-authorship network of co-authors of Kathryn E. Oliver

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn E. Oliver. A scholar is included among the top collaborators of Kathryn E. Oliver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn E. Oliver. Kathryn E. Oliver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Olson, John A., Eli Fritz McDonald, Jens Meiler, et al.. (2025). General trends in the calnexin-dependent expression and pharmacological rescue of clinical CFTR variants. eLife. 14.

Lopes‐Pacheco, Miquéias, Amanda Winters, John A. Olson, et al.. (2025). Recent developments in cystic fibrosis drug discovery: where are we today?. Expert Opinion on Drug Discovery. 20(5). 659–682. 1 indexed citations

McDonald, Eli Fritz, Kathryn E. Oliver, Jonathan P. Schlebach, Jens Meiler, & Lars Plate. (2024). Benchmarking AlphaMissense pathogenicity predictions against cystic fibrosis variants. PLoS ONE. 19(1). e0297560–e0297560. 17 indexed citations

Zhao, Conan, et al.. (2024). Racial inequities and rare CFTR variants: Impact on cystic fibrosis diagnosis and treatment. Journal of Clinical & Translational Endocrinology. 36. 100344–100344. 6 indexed citations

Mao, Yiyang, et al.. (2023). Features of CFTR mRNA and implications for therapeutics development. Frontiers in Genetics. 14. 1166529–1166529. 8 indexed citations

McDonald, Eli Fritz, Wesley D. Penn, Jens Meiler, et al.. (2023). General trends in the effects of VX-661 and VX-445 on the plasma membrane expression of clinical CFTR variants. Cell chemical biology. 30(6). 632–642.e5. 20 indexed citations

Oliver, Kathryn E., Marianne Carlon, Nicoletta Pedemonte, & Miquéias Lopes‐Pacheco. (2023). The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold?. Expert Opinion on Pharmacotherapy. 24(14). 1545–1565. 11 indexed citations

Rauscher, Robert, Disha Joshi, Lisa J. Strug, et al.. (2021). Positive epistasis between disease-causing missense mutations and silent polymorphism with effect on mRNA translation velocity. Proceedings of the National Academy of Sciences. 118(4). 23 indexed citations

Sabusap, Carleen Mae P., Disha Joshi, Kathryn E. Oliver, et al.. (2021). The CFTR P67L variant reveals a key role for N-terminal lasso helices in channel folding, maturation, and pharmacologic rescue. Journal of Biological Chemistry. 296. 100598–100598. 21 indexed citations

10.

Rauscher, Robert, Sebastian Kirchner, Kathryn E. Oliver, et al.. (2020). Global assessment of the integrated stress response in CF patient-derived airway and intestinal tissues. Journal of Cystic Fibrosis. 19(6). 1021–1026. 5 indexed citations

11.

Polte, Christine, Kathryn E. Oliver, Marcel J. C. Bijvelds, et al.. (2019). Assessing cell-specific effects of genetic variations using tRNA microarrays. BMC Genomics. 20(S8). 549–549. 18 indexed citations

12.

Oliver, Kathryn E., Robert Rauscher, Wei Wang, et al.. (2019). Slowing ribosome velocity restores folding and function of mutant CFTR. Journal of Clinical Investigation. 129(12). 5236–5253. 32 indexed citations

13.

Oliver, Kathryn E., Sangwoo T. Han, Eric J. Sorscher, & Garry R. Cutting. (2017). Transformative therapies for rare CFTR missense alleles. Current Opinion in Pharmacology. 34. 76–82. 20 indexed citations

14.

Veit, Guido, Kathryn E. Oliver, Pirjo M. Apaja, et al.. (2016). Ribosomal Stalk Protein Silencing Partially Corrects the ΔF508-CFTR Functional Expression Defect. PLoS Biology. 14(5). e1002462–e1002462. 46 indexed citations

15.

Oliver, Kathryn E. & Laura Silo-Suh. (2013). Impact ofd-amino acid dehydrogenase on virulence factor production by aPseudomonas aeruginosa. Canadian Journal of Microbiology. 59(9). 598–603. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact